title

Hepatology Solutions

 

title

The ever-growing challenge of caring for patients with Hepatitis C in Canada is a continued focus. Meeting patients where they are at will be essential in reaching optimal positive health outcomes for those living with Hepatitis C and in achieving the World Health Organization goal of elimination by 2030. The C Treat 2030™ program leaves no patient behind. It Connects individuals with Hepatitis C to Care and Continues to support them throughout their journey to a Cure.

title


Patients are our priority. With market-leading services in Hepatitis C patient support, McKesson Canada has developed the C Treat 2030™ program.


title


Connect

  • Focused Hepatitis C outreach in community based settings
  • Nursing team who meets patients where they are at
  • Easily accessible referral hub for providers and self referrals
  • Point of Care screening opportunities
  • Technology driven screening opportunities

 

 

 

 


Care

  • Hepatitis C screening, assessment and treatment done by expert clinicians
  • Linkage to low barrier treatment providers
  • Patient focused education
  • Harm reduction education
  • Agnostic medication access, reimbursement assistance and patient support program navigation
  • Specialized Hepatitis C pharmacist assessment, education and medication support

 

 


Continuity

  • Single point of contact over the course and following treatment
  • Advanced technology solutions to ensure follow up
  • Collaboration with other health care providers

title

The Access to Care Liver Health Program provides multi-faceted services to support patients living with liver disease. A2C (Access to Care) Liver Health is a one stop program that can assist patients and providers with various needs.

 

 

title


McKesson Canada has developed the first non pharmacologic Patient Support Program focused on Liver Health.


title

 


Connect

  • Identification of patients living with chronic liver disease
  • Linkage to healthcare providers via our assessment hub
  • Clinical pathway driven disease management focusing on supportive and curative options
  • Innovative programs for disease management
    • C Treat 2030™
    • HCV Treatment Support
    • NAFLD (Non-alcoholic fatty liver disease) Screening program
    • Chronic liver disease support

 


Care

  • Dedicated expert hepatology nursing team provides patient focused care
  • Disease management
  • Systems navigation
  • Facilitate screening and diagnostics
  • Diagnostic support
    • Point of Care testing
  • Expert clinical pharmacy team – medication reconciliation and drug interaction consultation
  • Comprehensive and agnostic medication access

 


Continuity

  • Expert Nursing and Clinical Support
  • Patient follow up and reminder calls
  • Diagnostic support
  • Patient directed education
    • diet and lifestyle management
    • harm reduction
    • weight management
  • Technology support to ensure up to date communication with providers

title

 

For more information please contact


Donna Zukowski
donna.zukowski@mckesson.ca
613-242-1216

Cheryl Dale
cheryl.dale@mckesson.ca
226-376-2740

 

 

McKesson Canada

2300 Meadowvale Boulevard
Mississauga, Ontario L5N 5S1
www.mckesson.ca
905-671-4586